greeksoup/ stock research

Insulet (PODD) Q4 FY2025 earnings: revenue $784 million, up 31.2% on the year

Insulet Corp. (PODD) reported revenue of $784 million for Q4 FY2025, the quarter ended 31 December 2025, up 31.2% on the same quarter a year earlier. Net income was $102 million, up 0.9% on the year, and diluted earnings per share $1.44. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2026.

Revenue
$784 million
+31.2% on the year · +11.0% on the quarter
Q1 FY2024Q4 FY2025
Operating margin
18.7%
18.3% a year earlier
Q1 FY2024Q4 FY2025
Net income
$102 million
+0.9% on the year · +16.0% on the quarter
Q1 FY2024Q4 FY2025
Diluted EPS
$1.44
+3.6% on the year · +16.1% on the quarter
Q1 FY2024Q4 FY2025

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 12 new.

  • Q4 revenue rose 31%, above guidance: Fourth-quarter revenue was $783.8 million, up 31.2% or 29.0% in constant currency, above the top of the 25% to 28% guidance range.
  • Adjusted EPS well above GAAP: Q4 GAAP diluted EPS was $1.44 and adjusted diluted EPS was $1.55. Full-year GAAP diluted EPS was $3.48 and adjusted diluted EPS was $4.97.
  • International revenue up 51% in Q4: International revenue was $214.0 million, up 50.7% or 41.7% in constant currency, with a 9.0 point currency effect. Full-year International revenue rose 44.1%.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ4 FY2025Q3 FY2025Q4 FY2024On the quarterOn the yearLast 8 quarters
Revenue784706598+11.0%+31.2%
Cost of revenue215196167+9.6%+29.1%
Gross profit569510431+11.5%+32.0%
Gross margin72.6%72.2%72.1%
Research and development90.977.260.6+17.7%+50.0%
Selling, general and administrative332315261+5.2%+27.0%
Operating income146118109+24.2%+33.8%
Operating margin18.7%16.7%18.3%
Interest expense15.015.68.7-3.8%+72.4%
Pre-tax income140123111+14.2%+26.0%
Income tax38.635.210.6+9.7%+264.2%
Effective tax rate27.5%28.7%9.5%
Net income10287.6101+16.0%+0.9%
Net margin13.0%12.4%16.9%
Diluted EPS$1.44$1.24$1.39+16.1%+3.6%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ4 FY2025Q3 FY2025Q4 FY2024On the quarterOn the yearLast 8 quarters
Operating cash flow183126148+45.8%+24.1%
Capital expenditure13525.653.6+427.7%+152.1%
Free cash flow48.210094.1-51.8%-48.8%
Free cash flow margin6.2%14.2%15.7%
Cash from investing-153-31.0-68.0
Cash from financing-72.5-457-20.9
Depreciation and amortisation24.422.021.5+10.9%+13.5%
Share-based compensation20.316.720.0+21.6%+1.5%
Buybacks0.029.5n/a
Diluted shares, weighted71m71m74m+0.0%-4.6%
Shares outstanding at period end70m70m70m+0.1%+0.3%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ4 FY2025Q3 FY2025Q4 FY2024On the quarterOn the yearLast 8 quarters
Shareholders' equity1,5151,3841,212+9.5%+25.1%
Debt9491,0151,380-6.5%-31.2%
Operating lease liabilities48.9n/a40.0+22.2%
Finance lease liabilitiesn/an/a0.0
Other liabilities677630456+7.4%+48.4%
Total liabilities and equity3,1903,0293,088+5.3%+3.3%
Goodwill51.651.651.50.0%+0.2%
Intangible assets11710598.5+11.5%+18.9%
Securities held for sale or to maturity0.0n/a4.7
Cash and equivalents716757953-5.5%-24.9%
Receivables517n/an/a
Inventory453446430+1.4%+5.2%
Other assets1,3361,6691,549-19.9%-13.8%
Total assets3,1903,0293,088+5.3%+3.3%

Questions

What was Insulet's revenue in Q4 FY2025?

Insulet (PODD) reported revenue of $784 million for Q4 FY2025, the quarter ended 31 December 2025, up 31.2% on the same quarter a year earlier.

How much did Insulet earn in Q4 FY2025?

Net income for Q4 FY2025 was $102 million, up 0.9% on the year, and diluted earnings per share $1.44.

When did Insulet report Q4 FY2025 results?

Insulet filed its 10-K for the year that ended with the quarter on 18 February 2026; the fourth quarter is the year less the first three.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024 †Q4 FY2024 *Q1 FY2025 †Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue308295299341370358396433510442488544598569649706784762802842
Cost of revenue94.585.7109152152118132139149135158167167160197196215233239210
Gross profit213210190188217240265293361307331377431409452510569529563632
Gross margin69%71%64%55%59%67%67%68%71%69%68%69%72%72%70%72%73%69%70%75%
R&D41.843.142.645.049.550.155.157.842.050.253.954.960.659.673.477.290.989.788.191.6
SG&An/a129174140144163179181213200222234261261258315332317345351
Operating income49.737.9-26.72.923.527.731.154.810656.954.688.110988.8121118146122130190
Operating margin16%13%-9%1%6%8%8%13%21%13%11%16%18%16%19%17%19%16%16%23%
Interest expense15.19.09.19.29.29.49.710.46.710.711.012.48.79.219.615.615.014.713.516.2
Pre-tax income33.429.3-36.1-5.722.324.628.553.710854.951.182.911148.228.4123140113119177
Tax rate13%5%n/an/a24%3%4%3%4%6%-269%7%10%26%21%29%28%19%20%20%
Net income29.227.8-35.0-5.217.023.827.351.910351.518977.510135.422.587.610291.195.0141
Net margin9%9%-12%-2%5%7%7%12%20%12%39%14%17%6%3%12%13%12%12%17%
Diluted EPS$0.43$0.40-$0.50-$0.08$0.24$0.34$0.39$0.74$1.44$0.73$2.59$1.08$1.39$0.50$0.32$1.24$1.44$1.30$1.37$2.03
Operating cash flow-25.5-13.725.356.750.70.544.056.045.287.696.598.514863.819612618311488.4124
Capital expenditure31.812.814.631.164.410.515.720.129.322.122.526.753.612.318.625.613524.332.557.1
Free cash flow-57.3-26.510.725.6-13.7-10.028.335.915.965.574.071.894.151.517810048.289.555.966.4
Buybacksn/an/an/an/an/an/an/an/an/an/an/a0.0n/a0.030.129.50.03000.00.0
Shares outstanding69m69m69m69m70m70m70m70m70m70m70m70m70m70m70m70m70m69m69m69m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-K for the period ended 31 December 2025, filed 18 February 2026: the filing.